Author: Marc Ethier
100 business schools named to the elite 5 Palmes tier, a group defined by global reach, international partnerships & cross-border influence.Read More
OTR Therapeutics has emerged from stealth with the closing of a $100 million Series A financing that strengthens the company’s strategy to advance early scientific innovation into globally deployable therapies. The funding round, completed in June 2025, was backed by True Light Capital, LAV, Pfizer Ventures, and Sirona Capital.Read More
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient has been dosed in Part 2 (randomized treatment expansion) of its ProstACT Global Phase 3 study evaluating its lead prostate cancer therapy candidate TLX591 (lutetium (177Lu) rosopatamab tetraxetan) in patients with metastatic castration resistant prostate cancer (mCRPC). The patient was dosed at the Australian Prostate Centre (APC) in Melbourne, Australia.Read More
Virginia Tech has hired former head coach Brent Pry to be the defensive coordinator under James Franklin, according to ESPN.Read More
The 12 teams that will compete in the 2025-26 College Football Playoff have officially been decidedRead More
One gets a first-round bye, another gets a juicy matchup with a blueblood program.Read More
The tech Right champions growth and discovery, while the populist Right stresses heritage and cultural values.Read More
As the Australian market experiences a tentative rise, with shares initially pointing towards gains before potential afternoon reversals, investors are closely monitoring economic indicators and broader market sentiment that could impact small-cap stocks. In this environment, identifying high-growth tech stocks involves looking for companies that can navigate these fluctuations effectively while capitalizing on technological advancements and strategic opportunities in the sector.Read More
Yellow Jackets await bowl destination after finishing in CFP top 25 for first time in 11 yearsRead More
For “life and death decision-making,” Anduril cofounder Palmer Luckey says it’s “too critical” to not use the most advanced technology.Read More